| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.04 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |